Folic Acid Has a Protective Effect on Retinal Vascular Endothelial Cells against High Glucose.
Zhenglin WangWei XingYongli SongHongli LiYonggang LiuYong WangChun LiYun WangYan WuJing HanPublished in: Molecules (Basel, Switzerland) (2018)
Diabetic retinopathy (DR) is a severe complication of diabetes, which seriously affects the life quality of patients. Because of the damage caused by DR, there is an urgent need to develop effective drugs. Folic acid, a water-soluble vitamin, is one of the vitamin B complexes. Folic acid is widely found in the meat and vegetables. In the clinic, low folic acid levels in the body may have a certain correlation with DR. However, there is no relevant basic research proving a relationship between folic acid levels and DR. The purpose of this study was therefore to investigate whether folic acid has a protective effect on the retinal vascular endothelial cells against high glucose levels. Moreover, the molecular mechanism of action of folic acid was further explored. The results showed that folic acid significantly suppressed the cell viability, tube length, migrated cells and the percentage of BrdU⁺ cells compared with the high glucose group. Moreover, folic acid decreased the mRNA expression of TEAD1 and the protein expression of TEAD1 and YAP1. These findings indicate that folic acid can protect retinal vascular endothelial cells from high glucose-induced injury by regulating the proteins in the Hippo signaling pathway.
Keyphrases
- high glucose
- endothelial cells
- diabetic retinopathy
- optical coherence tomography
- induced apoptosis
- signaling pathway
- editorial comment
- cell cycle arrest
- water soluble
- end stage renal disease
- vascular endothelial growth factor
- type diabetes
- oxidative stress
- endoplasmic reticulum stress
- primary care
- newly diagnosed
- pi k akt
- ejection fraction
- cardiovascular disease
- epithelial mesenchymal transition
- cell death
- peritoneal dialysis
- prognostic factors
- early onset
- metabolic syndrome
- quality improvement
- climate change
- patient reported outcomes
- risk assessment